Treating Patients With T2D and MASLD: Is the Tide Changing?
Naim Alkhouri, MD, FAASLD, DABOM
My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?
Robert H. Eckel, MD, FAHA, FACC, FNLA
You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?
MASLD in My Clinic: Hiding in Plain Sight?
More Screening Recommendations? These Could Save Your Patient's Life
Tessa Janovsky, PA-C
M3: Managing the Cardiometabolic Risk in MASH
It All Starts With a Patient
Jeff McIntyre
Endocrinologists and PCPs: The Frontline Defense Against Cirrhosis in Patients with Type 2 Diabetes
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, DMSc, MD
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Hyperkalemia in CKD and HFrEF…What Am I Missing?
George L. Bakris, MD, FAHA, FASN
David Bushinsky, MD
Lars Lund, MD
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Stephen J. Greene, MD, FACC, FHFSA
Is a Low-Carb, High-Fat Diet the Key to Diabetic Management?
Barnett Mennen, MD
Sarah Hallberg, MD
Home Monitoring of Blood Sugar Did Not Improve Glycemic Control After 1 Year
Hot Topic: Can Global Warming Affect Diabetes Rates?
Brian P. McDonough, MD, FAAFP